Mereo Biopharma Group Plc (MREO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MREO Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Mereo Biopharma Group Plc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent47.76
Cash And Cash Equivalents0.39
Cash & Short-term Investments47.00
Notes Receivable, Current0.32
Other Current Assets1.56
Prepaid Expense And Other Assets Current0.07
Total Current Assets52.78
Equipment/Property/Plant Net0.98
Intangible Assets0.38
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent2.09
Research And Development Incentives Receivables Current1.56
Total Assets53.55
Liabilities
Accounts Payable, Current AC4.25
Accrued Liabilities, Current AC0.61
Other Liabilities, Current0.91
Taxes Payable0.49
Total Current Liabilities8.14
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.02
Noncurrent Provisions2.38
Total Liabilities8.65
Stockholders' Equity
Common Stock Value4.15
Additional Paid In Capital Common Stock0.20
Retained Earnings / Accumulated Deficit-669.14
Accumulated Other Comprehensive Income-16.57
Other Equity-16.57
Common Stockholder's Equity44.90
Total Stockholder's Equity44.90
Liabilities & Stockholder's Equity53.55
4 historic quarters locked

Sign in to unlock the full Mereo Biopharma Group Plc balance sheet history.

About Mereo Biopharma Group Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-343533

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.